US Stocks
/
BioAge Labs, Inc. Share Price

BioAge Labs, Inc. Share Price

NASDAQ: BIOA | Micro Cap
$8.07
-$0.05 (-0.62%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

BioAge Labs, Inc. Stock Performance

Open
$7.92
Prev. Close
$8.12
Circuit Range
N/A
Day Range
$7.86 - $8.13
Year Range
$4.88 - $25.88
Volume
35,735
Average Traded
$7.98

BioAge Labs, Inc. Share Price Today

As of 19 September 2026, BioAge Labs, Inc.'s share price is $8.07. The stock opened at $7.92, compared to its previous close of $8.12. During today's trading session, BioAge Labs, Inc.'s share price traded between $7.86 and $8.13, with an average price of $8.00. Over the past 52 weeks, the stock has recorded a high of $25.88 and a low of $4.88. In terms of performance, BioAge Labs, Inc.'s share price has declined by 53.87% over the last six months and is up 36.09% on a year-on-year basis.

BioAge Labs, Inc. Share Price Chart

$7.86$8.13
L
Show Current Price
H

BioAge Labs, Inc. Stock Fundamentals & Key Indicators

Market Cap
$289.98M
PE Ratio (TTM)
-3.60
Dividend Yield
N/A
EPS (TTM)
$-2.24
Revenue (TTM)
$8.99M
Return On Equity (TTM)
-29.63%
Profit Margin
-896.11%
Debt to Equity
0.08
Quarterly Earnings Growth YoY
N/A

BioAge Labs, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2025Jun 2025Sep 2025
Revenue$1.45M$2.41M$2.05M
Net Profit-$12.93M-$21.56M-$20.17M
Net Profit Margin-890.97%-893.99%-982.04%
Income ChangeN/A-66.79%6.46%

BioAge Labs, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
RevenueN/A$8.99M
Net Profit-$71.11M-$80.61M
Net Profit MarginN/A-896.11%
Income ChangeN/A-13.35%

About BioAge Labs, Inc.

BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.

BioAge Labs, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$9.38
$8.09
-19.74%
Aug 2026
$9.61
$10.08
+11.50%
Jul 2026
$24.30
$9.04
-63.10%
Jun 2026
$17.16
$24.50
+41.91%
May 2026
$16.63
$17.27
+2.83%
Apr 2026
$17.91
$16.79
-4.03%
Mar 2026
$20.10
$17.50
-21.34%
Feb 2026
$19.73
$22.24
+16.90%
Jan 2026
$12.70
$19.02
+43.97%
Dec 2025
$9.14
$13.21
+40.14%
Nov 2025
$7.57
$9.43
+24.57%
Oct 2025
$5.96
$7.57
+27.66%

BIOA Share Price FAQs

What is BioAge Labs, Inc. share price today?

chevron-up
BioAge Labs, Inc. share price today is $8.07 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of BioAge Labs, Inc. stock?

chevron-up
The 52 week high of BioAge Labs, Inc. stock is $25.88, while the 52 week low is $4.88 as of 19 Sep '26.

What is BIOA's market capitalisation today?

chevron-up
BIOA market capitalisation is $289.98M as of September 19, 2026, at 6:46 pm IST.

What is BIOA's net income for the last quarter?

chevron-up
BIOA's net income for the last quarter is -0.02B USD.

What is the 5 year returns of BIOA?

chevron-up
The 5 year returns of BIOA is 4975.47% as on 19 Sep '26.

What is the high & low stock price of BIOA today?

chevron-up
BIOA stock price hit a high of $8.13 and low of $7.86 as of 19 Sep '26.

Can I buy BIOA shares in India?

chevron-up
Yes. You can buy BIOA in India by opening an international trading account.